Goldman Sachs Maintains Buy on Incyte, Lowers Price Target to $107; Keeps On Americas Conviction List

Goldman Sachs analyst Salveen Richter maintains Incyte (NASDAQ:INCY) with a Buy and lowers the price target from $122 to $107.

Benzinga · 01/03/2020 14:46

Goldman Sachs analyst Salveen Richter maintains Incyte (NASDAQ:INCY) with a Buy and lowers the price target from $122 to $107.